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The root of the Panax ginseng Meyer has been
a popular and widely used traditional herbal medi-
cine in Asian countries for thousands of years. The
popularity of P. ginseng as natural Chinese medicine
has increased globally and currently it is frequently
available in Western herbal preparations (1). P. gin-
seng is reported to have a wide range of therapeutic
applications ñ it has beneficial effects on cardiovas-
cular system, central nervous system, and immune
system (2). Nevertheless, ìthere is clearly a lack of
definitive evidence demonstrating any effects of P.
ginseng on human physical and mental performance
or any parameter related to perceived energyî (3, 4),
nor the evidence to claim all health benefits and
insure safety issues, as studies are often contradicto-
ry (4), which in fact is the case with many comple-
mentary and alternative medicines (CAMís) used
worldwide (5). In addition to the contradictory clin-
ical information about P. ginseng, only few interna-
tional studies have focused on the user perception
about P. ginseng (6).
P. ginseng arrived to Europe in the early
Middle Ages through Arabian merchants. However,
due to little awareness about medical properties of P.
ginseng, it became known only since 17-th century.
Nevertheless, medical doctors did not trust the mir-
acle remedy and P. ginseng was not included to most
European pharmacopoeias till 19-th century. A new
wave of popularity of P. ginseng has grown during
past fifty years. 
According to the European Medicines
Evaluation Agency (7), P. ginseng, as one-compo-
nent preparation, has been available in different
pharmaceutical formulations (tablets, powder, hard
and soft capsules, oral liquid and herbal instant tea)
in Germany, France and Sweden at least since mid-
dle of 1970s; in Austria, Ireland and Spain since
1980s and in Denmark, Poland and Portugal since
1990s. There is a large variability in the number of
different P. ginseng preparations available on the
market of different European countries starting with
60 different preparations in Germany and ending
with one to two in Austria, Belgium, Denmark,
Ireland and Portugal. In Italy and Latvia only com-
bination preparations containing P. ginseng and/or
vitamins, minerals and other components are avail-
able. According to regulatory status, P. ginseng
preparations are granted marketing authorization as
medicinal products in Austria, Belgium, Denmark,
France, Germany, Ireland, Latvia, Poland, Portugal
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and Spain. P. ginseng preparations are considered as
traditional preparations in Sweden and partly in
Germany, Poland and Spain (7). 
In Europe, P. ginseng is definitely one of the
medicinal plants which have contributed to the
adaptation of new exotic species into local CAMís
(8). Similarly to the description given in several
international studies about the use of P. ginseng (9-
12), this medicinal plant is considered well-known
and frequently used tonic available in community
pharmacies also in Estonia.
Estonia, a small country in the Northern
Europe, is one of the three Baltic States and border-
ing with Finland, Russia and Latvia. About 70% of
its 1.3 million population are Estonian-speaking,
while the rest of the population mostly speaks
Russian as their mother-tongue. Estonia is known
for intensive historical and modern use of local
native and cultivated medicinal plants for self-med-
ication of different minor conditions (13-17). In
addition, foreign medicinal plants (such as Mentha
piperita, Chamomilla recutita, Calendula officinalis
and Salvia officinalis) have been adopted to the
local culture or substituted with wild medicinal
plants (18). There are several alternative means of
information retrieval about the use of medicinal
plants: traditions or literary sources, previous per-
sonal experience as well as information provided by
healthcare professionals, usually pharmacist or doc-
tor (19-21).
Based on its history and location, Estonia has
been crossing of eastern and western culture and tra-
ditions. This could also be seen in the history of the
use of P. ginseng in Estonia. P. ginseng is a good
example of a foreign plant with no historical uses
detected in earlier local folklore (22). P. ginseng as
a wild species does not grow in Estonia and to date
cultivation of this medicinal plant has not been
established also (23). However, the P. ginseng
preparations have been available at local communi-
ty pharmacies starting from the last decades of 19-th
century as the latest (24). At that time, Estonia was
incorporated to the Russian Tsarist Empire. Russia,
known as country with traditional guidelines for
using P. ginseng (25), made these preparations also
accessible in the western regions of its territory.
During the First Republic of Estonia (1918ñ1940)
the economic and cultural contacts were developed
mostly with Western Europe and this could be one
of the reasons, why P. ginseng was not available at
community pharmacies, but was introduced again
after the Second World War in the middle of 1950s,
when Estonia was part of the Soviet Union (26). All
P. ginseng preparations now available in Estonia are
prepared from P. ginseng. While during Soviet peri-
od the promotion of medicinal products was
unknown in Estonia, the commercials were avail-
able in mass-media after regaining of independence
from the beginning of 1990s. In one of these com-
mercials aged Chinese men demonstrated the
human-like root of P. ginseng and introduced the
ginseng preparations to the Estonian people. 
There have been some analogues of P. ginseng
such as Eleutherococcus senticosus (Rupr. &
Maxim.), Rhodiola rosea L. (synonym Sedum rosea
(L.) Scop.) and Schisandra chinensis (Turcz.) Baill.,
traditionally used during Soviet period (1940-1991)
in Estonia (27) and/or tinctures, liquid extracts,
tablets or capsules of described medicinal plants are
available also in present time.
In some countries, including Estonia, ginseng
has been perceived as a cultural representation of
Chinese Medicine. Although, the medicine is well
known and widely available, the public perception
on the use of ginseng and its analogues are poorly
studied in international literature.
To fill this knowledge gap, this study was
aimed to evaluate the pattern of complementary self-
treatment with P. ginseng and its analogues
(Eleutherococcus senticosus, Rhodiola rosea, and
Schisandra chinensis) amongst pharmacy customers
in Estonia.
METHODS
Study design
Convenience sample of Estonian and Russian
speaking pharmacy customers in three different
towns of Estonia was used. Tartu (located in South-
Estonia, population about 100,000) is the second
biggest town in Estonia, where the majority of per-
manent residents are Estonian speaking. In the capi-
tal city of Estonia, Tallinn (located in North-Estonia,
population about 400 000), the number of Russian
speaking permanent residents is higher. In Kohtla-
J‰rve (located in North-East Estonia close to
Russian boarder, population about 40,000) a major-
ity of the population are Russian speaking. In
Tallinn, the study was undertaken in three commu-
nity pharmacies in other two towns only one phar-
macy was selected. All community pharmacies can
be classified as medium size (approx. 30,000 pre-
scriptions per year) pharmacies with large selection
of non-prescription medicines and herbal products. 
Two independent researchers conducted the
study at the same period (June-August) in Tartu and
Kohtla-J‰rve (2011) and in Tallinn (2012). In all
community pharmacies customers approaching to the
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counter of non-prescription medicines were invited to
participate in the study. The research assistant
explained the purposes of the study and oral informed
consent was received from all interviewed pharmacy
customers. In both, Tartu and Kohtla-J‰rve communi-
ty pharmacies, 300 respondents were interviewed, in
Tallinn 650 respondents were involved in the study.
In total, 1250 pharmacy customers participated in the
study. However, as 17 questionnaires were incom-
plete, the analysis was carried out with 1233 replies.
The number of pharmacy customers which refused to
participate in the study was not documented. For
those respondents who never used P. ginseng or its
analogues, only demographic data were collected.
Respondents were interviewed in their native lan-
guage (either Estonian or Russian) and only local res-
idents participated in the study.
Study instrument
The study instrument was developed and dis-
cussed by a panel of researchers with a pharmaceu-
tical background and extended knowledge in phy-
totherapy, ethnobotany, social pharmacy and semi-
otics. The study instrument applied was developed
by using previous study models for evaluating self-
medication with OTC medicines including medici-
nal plants (17, 20, 21, 28). A copy of the study
instrument can be obtained from the corresponding
author.
The study instrument consisted of multiple-
choice items related to (1) personal knowledge or
experience of the use of P. ginseng, (2) time and
duration of the use, (3) specific preparation or form
used, (4) purpose of the use and perceived effects,
(5) mode of action and side effects of P. ginseng and
its analogues, and (6) demographic characteristics of
the respondent. 
In Europe, P. ginseng preparations are used as
a tonic in case of tiredness, weakness and decreased
mental and physical capacity (7). These indications
have been presented in package information leaflets
of P. ginseng preparations marketed in Estonia and
were pre-listed to assist respondents in selection of
appropriate descriptions. In addition respondents
could describe other indications, for what P. ginseng
was used.
In addition to P. ginseng use, the study partici-
pants were asked to recall the use and efficacy of its
analogues. Three different species were listed by
their vernacular names in study instrument as to
understand what analogues were used: E. senticosus,
R. rosea and S. chinensis. 
To assist the identification of the preparations
nine different photos of preparations of P. ginseng
available at the period of study were demonstrated to
the respondents (Fig. 1). The pictures worked as trig-
gers for activating mental herbal of the respondents
(term proposed by Ko≥odziejska-DegÛrska) (29).
Based on the experience of this study, several respon-
dents recalled their use of P. ginseng only after seeing
the pictures of the preparations. P. ginseng analogues
were not illustrated with actual preparations.
Figure 1. Pictorial representations of the P. ginseng preparations which were available and were shown to the respondents during the inter-
view: 1. Gerimax tablets of ginseng extract; 2. Gerimax tablets of ginseng extract with vitamins and minerals; 3. Gerimax liquid extract of
ginseng; 4. Ginseng N liquid extract of ginseng; 5. Dynamisan tablets of ginseng extract; 6. Strong GinSeng tablets of ginseng extract; 7.
Zhenchenya nastoika tincture of ginseng; 8. Vishpha tincture of ginseng; 9. Spectrum capsules of ginseng with vitamins, minerals, rutin
and lecithin
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The content validity and comprehensibility of
the study instrument was pre-tested by ten random-
ly selected pharmacy customers of participating
community pharmacy in Tartu. Minor changes to
the wording of the items were made, based on feed-
back received.
This research did not use identifiable human
material or data. The survey conforms to the
Declaration of Helsinki and the ethical standards of
Estonia. The researchers have fulfilled the Data
Protection Act of Estonia.
Statistical analysis
Initial data were coded, inserted and stored in
MS Excel database. For statistical analysis SPSS v.
10 was used and for calculation of statistical signif-
icance between demographic groups Pearsonís χ2
test was applied. Level of statistical significance
was set at p ≤ 0.05. 
RESULTS
Frequency of P. ginseng and its analogues use
Of all study participants, 18.1% (n = 223)
reported the use of P. ginseng of whom 49 respon-
dents (4.0%) in addition consumed P. ginseng ana-
logues in their lives (Table 1). Of the users, 48.9%
(n = 109) had used P. ginseng preparation up to four
years prior to the study, 31.4% (n = 70) five to ten
years and 6.7% (n = 15) more than ten years ago.
Described distribution could be seen as a signal
about relatively recent popularity of P. ginseng in
Estonia.
Of the P. ginseng users, 67.3% (n = 150)
reported single and 32.7% (n = 73) repeat use of this
medicinal plant. These results demonstrate rather
medium interest towards P. ginseng preparations.
However, the repeat use of P. ginseng preparations
could be connected with positive effect of these
preparations as only five study participants (6.8%)
reported not having any effect and 30.1% (n = 22)
could not determine the positive effect in case of
multiple use of P. ginseng.
Duration of the use might also contribute to
perceived satisfaction of selected preparation. Of the
P. ginseng users, 38.6% (n = 86) consumed these
preparations for more than one month during one
course of the treatment, 35.4% (n = 79) for 2-3
weeks, 19.3% (n = 43) for less than a week and 6.7%
(n = 15) claimed using P. ginseng more or less con-
stantly. 
The most popular of the three proposed species
of P. ginseng analogues was E. senticosus (indicated
32 times). Rather popular was also R. rosea L. (22
times). To some extent S. chinensis was used less
(named 5 times). Of the users of P. ginseng ana-
logues 14.3% (n = 7) had used two and only 4.1% (n
= 2) all three species of analogues. 
Demographic data of non-users and users of
P. ginseng were compared. With increase of age
and among senior residents (both p < 0.01), peo-
ple speaking Russian as native language (p =
0.02) and with lower levels of education (p =
0.04), the use of P. ginseng was less frequent. On
the other hand, the use of P. ginseng was more
common amongst working people and those with
university degree and with better self-evaluated
health (p = 0.003). Described results could be
explained with reduced need for stimulants in
older age and possible lack of awareness about
exotic remedy among people with lower levels of
education. More frequent use of P. ginseng in
Figure 2. Self-evaluated health and perceived positive effect of P. ginseng preparations 
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Tartu (known as a town with one of the oldest uni-
versities in Northern Europe) could be connected
with higher number of inhabitants with university
degree.
P. ginseng preparations used
Of the 212 respondents which answered to the
question, 75.0% (n = 159) claimed the use of only
one specific P. ginseng preparation and 18.4% (n =
Table 1. Socio-demographic characteristics of non-users and users of P. ginseng. 
Non-users Users Statistical
n = 1010 % n =223 %  significance
(p < 0.05)
Age (years) p < 0.01
16-30 250 24.8 46 20.6
31-45 269 26.6 75 33.6
46-60 205 20.3 65 29.1
61-75 202 20.0 35 15.7
75+ 84 8.3 2 0.9
Gender ns
Female 665 65.8 158 70.9
Male 345 34.2 65 29.1
Education p = 0.04
Elementary school 43 4.3 2 0.9
High school 228 22.6 39 17.5
Vocational education 288 28.5 70 31.4
University degree 451 44.7 112 50.2
Native language p = 0.02
Estonian 621 61.5 158 70.9
Russian 389 38.5 65 29.1
Occupation p < 0.01
Working 544 53.9 157 70.4
Student 81 8.0 16 7.2
Senior 267 26.4 29 13.0
Unoccupied 61 6.0 6 2.7
Working student 43 4.3 8 3.6 
Working senior 14 1.4 7 3.1
Self-graded health p < 0.01
Very good 167 16.5 24 10.8
Good 458 45.3 107 48.0
Average 230 22.8 73 32.7
Satisfactory 134 13.3 17 7.6
Unsatisfactory 21 2.1 2 0.9
Place of interview p < 0.01
Tartu 296 29.3 73 32.7
Kohtla-J‰rve 297 29.4 43 19.3
Tallinn Tnism‰e 202 20.0 37 16.6
Tallinn Mustam‰e 141 14.0 12 5.4
Tallinn Pirita 297 29.4 58 26.0 
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39) at least two different preparations. The rest of
the respondents did not use preparations showed to
them on the illustration or did not remember the spe-
cific preparations they used. Among the depictured
preparations (Fig. 1) the most popular were tablets
and solution containing P. ginseng as single compo-
nent (no. 1-3) all together named 89 times and in
combination with vitamins and minerals (no. 5), 13
times (Fig. 1). The pattern of those respondents
reported only the use of mono-component P. ginseng
preparations was similar to the all users of P. gin-
seng. 
Selected preparations signal that a majority of
the respondents reporting the use of P. ginseng, pre-
ferred to take tablets. The popularity of tablets was
also confirmed by the parallel question addressing
the preferred form of preparation, where tablets or
capsules were used more frequently by 57.0% (n =
127) of the respondents and tinctures or liquid
extracts by 20.2% (n = 45) of the respondents. More
than half of the respondents, who had used tablets
and capsules, reported positive effects of P. ginseng
(p = 0.032). 
Purpose of use and perceived effects of P. ginseng
and its analogues
Of the respondents which used P. ginseng,
57.8% (n = 129) used those preparations for one and
the rest for multiple indications. More popular sin-
gle indications were general stimulation - 22.9% (n
= 51), increase of mental capacity 17.0% (n = 38)
and immune-stimulation 13.0% (n = 29). In addi-
tion, health recovery, increasing of appetite and
blood pressure and antidepressant activity were
mentioned by only few respondents. Of the multiple
applications more popular were the combinations of
general stimulation and an increase of mental capac-
ity 13.5% (n = 30). 
Despite whether P. ginseng preparations were
used for single or multiple indications, only 46.2%
(n = 103) of the respondents claimed that their
health problem was solved; while 15.7% (n = 35)
study participants reported that there was no effect.
The rest of the respondents 38.1% (n = 85) could not
evaluate if the P. ginseng preparation was effective
or not. 
Respondents who considered their health as
very good, good or average experienced more posi-
tive effect of the P. ginseng intake than those with
satisfactory or unsatisfactory self assessment of their
health condition (p < 0.01) (Fig. 2). Rather surpris-
ingly, residents of Tallinn experienced less positive
effect of P. ginseng intake than residents of Tartu
and Kohtla-J‰rve (p = 0.03). This may be related to
speed-up living in Tallinn, the capital city of Estonia
and hence probable higher expectations to a ìmira-
cleî medicine. 
Of the P. ginseng analogue users, more than
half (57.1%) claimed positive outcome of the treat-
ment. The rest was not able to comment on the influ-
ence of the P. ginseng analogues on their health
34.7% (n = 17) or they did not experience any effect
of its analogues 8.2% (n = 4).
Side-effects of P. ginseng preparations
Of the study participants used P. ginseng,
13.5% (n = 30) reported side effects. More frequent
problems were 4.5% increased blood pressure (n =
10) and gastrointestinal tract irritation 3.6% (n = 8),
but also anxiety 1.8% (n = 4), insomnia, arrhythmia
and nasal bleeding 0.5% (n = 1). One respondent
(0.5%) had experienced several side effects. 
DISCUSSION
This is the first study in Estonia exploring the
use for self-treatment and knowledge about exotic
medicinal plants ñ P. ginseng and its analogues. The
study results serve as a good example of newly
introduced and widespread herbal product in
Northern Europe. 
Only few international studies have evaluated
the frequency in the use of P. ginseng preparations.
In those studies the number of respondents who
have used P. ginseng within specified period of time
varies within a wide range and is dependent on
demographic characteristics. A study conducted
among Sikh (Punjabi) community in London found
the rate of citation to be 12% (11). This is still in
times higher than in a study conducted in USA,
where Cherniack and co-authors (12) found that 5%
of the subset of respondents used P. ginseng prepa-
rations for self-treatment and the use rate among
white population was even below 1%. 
The high proportion of the users of P. ginseng
detected in this study could be explained by cover-
ing the life-time period and questioning the respon-
dents at the pharmacies, not covering the part of the
population that do not attend pharmacies regularly.
In Northern Europe P. ginseng combined with min-
erals was found to be particularly popular among
Swedish women (6), but such preference was not
confirmed by this study. 
Priority given to tablets could be explained as
well with the ease of taking ones, but also that
tablets are culturally accepted form of medicine in
Estonia for already longer period of time. Although
the intake of liquids in form of medicinal teas is
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rather common in Estonia (16), the intake of tinc-
tures containing alcohol appears to be of less cultur-
al importance. It could be explained with tinctures
and infusions contain most often alcohol, which can
influence the ability to drive, although the quantities
are small.
In this study, the popularity of P. ginseng and
its perceived effects as a stimulant is worthy of
attention, demonstrating rather well defined position
of the P. ginseng preparations within the herbal land-
scape of Estonians. The use of stimulants in
Estonian traditional medicine is not common or at
least it was not perceived as such, although immune-
stimulation could be seen as one of the reasons to
use medicinal plants for prevention of cold and cold
relate diseases, which was rather popular already in
19th century (17, 22).
The perception of the study participants on the
safety and the side effects of ginseng corresponds
with former international research that has described
P. ginseng as herbal preparation with a good safety
profile and low incidence of adverse effects (30) and
a double-blind, placebo-controlled, parallel group
clinical study reported mild adverse events as dys-
pepsia, hot flash, insomnia and constipation in both
placebo and P. ginseng group subjects (31).
Study limitations
The study did not include the entire population,
but only the samples of pharmacy customers in three
different regions of Estonia. However, community
pharmacies are the most frequent places where one
can purchase P. ginseng preparations in Estonia and
selected study sample and setting created the foun-
dation for collecting the reliable information.
The selection of illustrated P. ginseng prepara-
tions was limited to those available at community
pharmacies at the time of the study. This could be
the reason why the participants who had used P. gin-
seng preparations more than five years ago did not
recall correctly the used preparation. 
CONCLUSIONS
This study gives initial information about lay
perception and use of P. ginseng and its analogues,
based on the sample of pharmacy customers in
North-European country Estonia. Based on the
results, the sample customer of P. ginseng is a mid-
dle aged (31-60 years) Estonian female with univer-
sity degree and a good health. 
In comparison with other studies and consider-
ing the region, the use of P. ginseng was rather fre-
quent ñ about 1/5 of the study participants. P. gin-
seng preparations were used mostly according to the
well-known indications - tiredness, weakness and
decreased mental and physical capacity. Thus, P.
ginseng could be seen as a helping tool in the treat-
ment of such conditions, where the use of tradition-
al medicinal plants of Estonia has not been well-
established (e.g., mental stimulation).
The efficacy of P. ginseng and its analogues
was evaluated similarly ñ about half of the users
experienced positive effects, 1/3 could not deter-
mine the effects and the rest did not experience any
improvement of their condition. Described out-
comes support the results of international studies
about inconsistency of P. ginseng efficacy. On the
other hand, evaluation of the efficacy of analogues
on the similar level with more studied P. ginseng
demonstrate existing practical experience of
Estonian pharmacy customers about the use of dif-
ferent exotic medicinal plants.
Although the study gives a short overview con-
cerning the frequency and content of side effects
experienced by P. ginseng users, the future research
has to concentrate more on the safety aspects (inter-
actions, contraindications) of P. ginseng and its ana-
logues.
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